ENTEROTOXICITY OF HEAT-STABLE ENTEROTOXIN PRODUCED FROM ENTEROTOXIGENIC ESCHERICHIA COLI
产肠毒素大肠杆菌产生的热稳定肠毒素的肠毒性
基本信息
- 批准号:09670289
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Heat-stable enterotoxin receptor (STaR/GC-C) is a member of membrane-associated guanylyl cyclase (GC) family. As compared with other GC receptors, following GC catalytic domain, STaR has prolonged carboxy-terminal tail which is about 60 amino acids longer than NPR-A (CC-A) and NPR-B (CC-B), and about 30 amino acids longer than GC-D, retGCl (GC-E), and retGC2 (GC-F). To elucidate the functional role of the additional carboxy-terminal tail, we examined the GC activities of two truncate STaR mutants, CDELTA1015 and CDELTA1023, which lack Gu^1^0^1^5-Phe^1^0^5^0 and Lys^1^0^2^3-Phe^1^0^5^0, respectively. After incubation with I jiM STa, the cells expressing CDELTA1O15 and CDELTA1023 accumulated about 20- and 10-folds higher cGMP than the cells expressing wild-typc STaR.The basal level of cGMP contents were not different between the cells with wild-type STaR and STaR mutants. Furthermore, the difference of CC activity was not observed at protein expression level. In addition, removal of carboxy-terminal tail of STaR induced not only high maximum level of cGMP-production but also high potential level of cGMP-produciion. These results suggest that the carboxy-terminal region of STaR might have an inhibitory function of STa-mediated GC activation, and therefore the lack of the carboxy-terminal region allowed to be activated high GC activity by STa.STaR and its N-terminal extraceltular domain were prepared at a high level of expression from a system constructed of Sf21 insect cells and recombinant baculovirus. The recombinant STaR retained its binding activity to STa with a Rd value of 6.2x10^-^1^0^0M and cyclase catalytic activity at a level similar to those of STaR expressed jn mammalian cell lines, such as COS-7.
热稳定的肠毒素受体(Star/GC-C)是膜相关的鸟叶基环酶(GC)家族的成员。与其他GC受体相比,遵循GC催化结构域,Star的羧基末端尾巴长约60个氨基酸,比NPR-A(CC-A)和NPR-B(CC-B)长约60个氨基酸,并且比GC-D,RETGCL(GC-E)和RetGC2(GC2(GC-F)长30个氨基酸。为了阐明其他羧基末端尾巴的功能作用,我们检查了两个缺乏GU^1^1^0^1^1^5-PHE^1^1^0^5^0的GC活性,分别是CDELTA1015和CDELTA1023,分别缺乏GU^1^1^1^1^1^5^0和Lys^1^1^0^0^2^3-PHE^1^1^0^0^0^5^5^0。与I Jim Sta孵育后,表达CDELTA1O15和CDELTA1023的细胞与表达野生型恒星的细胞相比,CGMP含量的基础水平与野生型恒星和恒星串扰的细胞之间的基础水平没有差异。此外,在蛋白质表达水平上未观察到CC活性的差异。此外,恒星的羧基末端尾部不仅引起了高最大CGMP产生水平,而且还引起了CGMP生产的高电位水平。这些结果表明,恒星的羧基末端区域可能具有STA介导的GC激活的抑制作用,因此,缺乏STA.STAR及其N末端的GC活性激活的羧基末端区域,以高水平的SF21昆虫细胞和Reculovirus构建的系统在高水平的表达中制备了高GC活性。重组恒星以6.2x10^ - ^1^0^0m的RD值保持其与Sta的结合活性,并以类似于Star表达的JN哺乳动物细胞系(例如COS-7)的水平,环酶催化活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yahiro,K.et al.: "Helicobacter phlorivacuolating cytotoxin binds to the 140-kDa protein in human gastric cancer cell lines, AZ-521 and AGS." Biochem.Biophys.Res.Commun.238. 629-632 (1997)
Yahiro,K.等人:“幽门螺杆菌细胞毒素与人胃癌细胞系 AZ-521 和 AGS 中的 140-kDa 蛋白结合。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Makoto Hasegawa et al.: "Expression and characterization of the extracellular domain of guanylyl cyclase from a baculovirus and sf21 insect cells." Protein Expression and Purification.15 印刷中. (1999)
Makoto Hasekawa 等人:“杆状病毒和 sf21 昆虫细胞中鸟苷酸环化酶胞外结构域的表达和表征。”15 已出版(1999 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Oishi,K.et al.: "Nitrite reductase from Pseudomonas aeruginosaiduces inflammatory cvtokines in cultured respiratory cells." Infect.Immun.65. 2648-2655 (1997)
Oishi, K. 等人:“来自铜绿假单胞菌的亚硝酸盐还原酶在培养的呼吸细胞中诱导炎症细胞因子。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Naoya Ohmori et al.: "Importance of hydrophobic region in amphiphilic structures of α-helical peptides for their gene transfer-ability into cells." Biochem.Biophys.Res.Commun.245. 259-265 (1998)
Naoya Ohmori 等人:“α-螺旋肽的两亲结构中的疏水区域对于其基因转移到细胞中的能力的重要性。”Biochem.Biophys.Res.Commun.245 (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Toshiya Hirayama,Akihiro Wada.: "Heat-Stable Enterotoxin of E.coli" Handbook of Experimental Pharmacology. volume:“Becterial Protein Toxin".印刷中. (1999)
Toshiya Hirayama、Akihiro Wada.:“大肠杆菌的热稳定肠毒素”实验药理学手册:“细菌蛋白毒素”(1999 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIRAYAMA Toshiya其他文献
HIRAYAMA Toshiya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIRAYAMA Toshiya', 18)}}的其他基金
Analysis of gene expression of Helicobacter pylori VacA
幽门螺杆菌VacA基因表达分析
- 批准号:
24659199 - 财政年份:2012
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis on multifunctional receptors for Helicobacter pylori VacA
幽门螺杆菌VacA多功能受体分析
- 批准号:
22390084 - 财政年份:2010
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Toxicity of Helicobacter pylori VacA and its mutual effect with CagA
幽门螺杆菌VacA的毒性及其与CagA的相互作用
- 批准号:
19209014 - 财政年份:2007
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Comparison of virulence factors produced by Helicobacter pylori between Philippine and Thailand
菲律宾与泰国幽门螺杆菌毒力因子比较
- 批准号:
18406015 - 财政年份:2006
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on the function of receptor for Helicobacter pylori VacA and the mechanism of its intoxication
幽门螺杆菌VacA受体功能及其中毒机制研究
- 批准号:
17209015 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Mechanism of Helicobacter pylonVacAintoxication
幽门螺杆菌疫苗中毒机制
- 批准号:
16017280 - 财政年份:2004
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Research for comparison of VacA in H. pylori infectious diseases
VacA在幽门螺杆菌感染性疾病中的比较研究
- 批准号:
14406007 - 财政年份:2002
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
TOXICITY OF HELICOBACTER PYLORI VACA TOXIN THROUGH ITS CELLULAR RECEPTOR
幽门螺杆菌毒素通过其细胞受体的毒性
- 批准号:
13670276 - 财政年份:2001
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
RECEPTOR OF HELICOBACTER PYLORI VACA TOXIN AND ITS SIGNAL FOR TOXIXITY
幽门螺杆菌毒素受体及其毒性信号
- 批准号:
11670266 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ADP-RIBOSYLTRANSFERASE OF HELIOBACTER PYLORI
幽门螺杆菌 ADP-核糖基转移酶
- 批准号:
09044322 - 财政年份:1997
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似国自然基金
产肠毒素大肠杆菌CFA/I菌毛的生成机制研究
- 批准号:32200992
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
细胞铁死亡与产肠毒素大肠杆菌引起的仔猪肠道损伤的关系及其营养调控
- 批准号:
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:
产肠毒素大肠杆菌CFA/I菌毛的生成机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
产肠毒素大肠杆菌热敏肠毒素诱导仔猪小肠上皮细胞凋亡及其分子机制的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
产肠毒素大肠杆菌热敏肠毒素诱导仔猪小肠上皮细胞凋亡及其分子机制的研究
- 批准号:32273002
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
相似海外基金
Mechanisms underlying diarrhea and gut inflammation mediated by Enterotoxigenic and Enteropathogenic E. coli
产肠毒素和致病性大肠杆菌介导的腹泻和肠道炎症的机制
- 批准号:
10674072 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Investigating the tissue location and protective function of oral vaccine-specific tissue resident memory CD4 T cells
研究口服疫苗特异性组织驻留记忆 CD4 T 细胞的组织定位和保护功能
- 批准号:
10646930 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
治疗类风湿关节炎的新型免疫导向生物疗法
- 批准号:
10760183 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
- 批准号:
10741541 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别: